Beacon Securities head of research, Toronto-based Doug Cooper, analyzed New Look Vision Group’s latest acquisition and concluded that the transaction not only grows New Look’s store count by about 66   Read More

‘Le jour de gloire est arrivé,’ according to Equium Capital Management president Cameron Hurst. Mr. Hurst sees more stability in Germany and riskier opportunities in Italy and Spain, but he   Read More

Cyclical investing works if the timing is right. The key question is: “Is this the right time?” Our current expansion (begun in 2009) is getting long in the tooth. Sectors   Read More

The S&P/TSX hasn’t shared in the current strength of global stock markets. In fact, the Toronto market has lost ground since it reached an all-time high in February. Only a   Read More

Portfolio manager Lorne Zeiler picks a US-based global healthcare stock and a Canadian preferred share exchange traded fund as his current two ‘best buys’ for investors seeking high dividend income   Read More

Hero today, Zero tomorrow. That’s how ValueTrend portfolio manager Keith Richards reminds himself that sector rotation is becoming faster and more pronounced of late. So who’s hot, and who’s not?   Read More

Medtronic PLC is a medical technology stock. It earned record profits in the year ended April 28. It’s expected to earn record profits in fiscal 2018 (which began April 29)   Read More

When you buy stocks in sectors and sub-sectors of the market, keep your portfolio balance goals in mind. If you’re a conservative, income-seeking investor, focus on utilities, financial and consumer   Read More

We’ve added Beutel Goodman American Equity to our list of ‘The Top 40: Canada’s Best Mutual Funds’ in the category of recommended equity mutual funds that invest mainly in U.S.   Read More

Another player recently joined the rapidly growing list of publicly-traded marijuana stocks in Canada. Writing in Investor’s Digest of Canada, Zachary McCrossin says WeedMD Inc.’s chief executive officer has a   Read More

Sentry Investments executive Andy Nasr looks to the United States, especially the financial, consumer staples, healthcare, technology, construction and infrastructure sectors, as good places to invest now. When pressed to   Read More

Healthcare stock Emblem Corp. is a Canadian licensed producer of medical marijuana, providing patients with high-quality, premium cannabis strains. It has recently sourced a supply of high-cannabidiol marijuana from a   Read More

A pullback is unlikely to sink a strong bull market in equities, yet it could offer investors an ideal opportunity to increase exposure to a sector of the market that   Read More

An infrastructure stock and a healthcare stock sound like an odd couple for investment counsellor Robert Sneddon’s two ‘best buy’ stock selections. But Mr. Sneddon forecasts a strong bull run   Read More

Dominant global technology stock Alphabet Inc. (parent of Google) and renewable energy stock Algonquin Power and Utilities are the two best stocks to buy now says Toronto-based Sentry Investments analyst   Read More

Gold and gold mining stocks will benefit from the turbulence of the Trump presidency. And, analyst David Chapman writes in Investor’s Digest of Canada, the amount of new gold being   Read More

Continue to add to your Canadian equity mutual funds portfolio. Aggressive small-cap equity mutual funds are starting to reward risk takers now.
Economic data and market sentiment have improved in recent   Read More

Canopy Growth is a diversified cannabis company engaged in growing and distributing medical marijuana products to patients across Canada. Mettrum Health Corp. is also a producer of medical cannabis and   Read More

Dominant global technology stock Alphabet Inc. (parent of Google) and renewable energy stock Algonquin Power and Utilities are the two best stocks to buy now says Toronto-based Sentry Investments analyst   Read More

Regular MoneyLetter columnist John Stephenson offers his stock market outlook for the early days of a Trump administration. Financial stocks should be among the first big winners because of the   Read More

American Depositary Receipts, or ADRs, give you benefits. One is global portfolio diversification. It’s tempting to call ADRs American ‘Diversification’ Receipts. They give you industries that Canada lacks or has   Read More

Loblaw Companies is a very conservative defensive consumer stock with a low beta of 0.518 which makes it an excellent choice for income investors seeking stocks that are considerably less   Read More

Sentry Investments analyst Andy Nasr identifies two U.S. stocks that will continue to prosper regardless of the U.S. election results. One is a pharmacy operator popular with drugstore-cowboy seniors. The   Read More

Follow the money into cyclical emerging markets or hunker down with some steady defensive stalwarts? The MoneyLetter’s regular investment strategy columnist John Stephenson recommends a combination of two emerging market   Read More

CRH Medical offers services and related medical instruments and equipment to physicians focused on providing screening and treatment of gastrointestinal ailments. Investment dealer Acumen Capital says the CRH Q2 results   Read More

Technical analyst and portfolio manager Keith Richards says bonds, utilities and consumer staples tend to do well in the weaker market months of May to November. He names some favourite   Read More

If death and taxes are certain, then surely their close siblings, aging and debt, are never too far away. Portfolio manager Robert McWhirter has found a healthcare stock and a   Read More

Technical analyst and portfolio manager Keith Richards says bonds, utilities and consumer staples tend to do well in the weaker market months of May to November. He names some favourite   Read More

John Stephenson, portfolio manager and president of Toronto-based Stephenson & Company Capital Management Inc., says that drug spending is unlikely to outpace the growth of other healthcare costs in the   Read More

A frequent contributor to Investor’s Digest of Canada, Elvis Picardo is on a roll. His picks for the popular ‘Best Buys’ from Leading Analysts column in December, 2015, and March,   Read More

3M Co. is expected to earn record profits this year and next. This will give this U.S.-based global manufacturing stock the means to keep rewarding its shareholders. While not cheap,   Read More

Reflecting on the rise and fall of one-time TSX favourite healthcare stock Valeant Pharmaceuticals, performance improvement specialist Sam Watts warns readers that a company’s continuous acquisitions can cause management to   Read More

Recurring seasonal effects can and do occur even in so-called efficient markets that are supposed to reflect all relevant news and information. (For example, the cost of heating your home   Read More

U.S.-based global stock 3M Co. is expected to earn record profits this year and next. This will give it the means to keep rewarding its shareholders. While not cheap, 3M   Read More

Your best long term strategic investment plan is to balance your portfolio across the five main sectors of the economy: finance, utilities, consumer products and services, manufacturing and resources. Each   Read More

Jean Coutu Group’s earnings are rising very slowly. But with lots of cash and excess cash flow, this debt-free consumer goods stock can afford to continue paying rising dividends. It   Read More

The cash-strapped Quebec government’s move to introduce a tendering system to lower generic drug prices dragged down the share price of top retail grocery chains Loblaw Cos. and Jean Coutu   Read More

Analysts follow as many as 20 stocks, most of which are rated ‘buys’.  Of those buys, an analyst has one or two special favourites seen as the best stocks to   Read More

Despite warnings of rich valuations from the U.S. Federal Reserve, investors in biotech stocks continued to snap up anything that moved. Elvis Picardo, vice president, research, and portfolio manager at   Read More

Analysts follow as many as 20 stocks, most of which are rated “buys.” Of those buys, an analyst has one or two special favorites seen as most suitable for new   Read More

Headquartered in Vancouver, CRH Medical sells products and services to doctors who screen and treat gastrointestinal ailments. Until recently, CRH was a medical device company, boasting a single product. But   Read More

In the second quarter of 2015, the value of takeovers in the pharmaceutical and biotech sector topped US$1 trillion. And now Montreal-based drug giant Valeant Pharmaceuticals is offering US$1 billion   Read More

Healthcare stock Johnson & Johnson offers attractive, rising dividends. It’s what’s known as a “dividend aristocrat”. In the U.S., that’s a firm that has hiked its dividend for at least   Read More

Baby boomers may increasingly whine about their creaking bodies.  But a positive side to their groans and moans for healthcare solutions is the growing need for drugs — particularly prescription   Read More

The TSX Venture Exchange is not your father’s stock exchange. Elvis Picardo, vice president of research and portfolio manager at Global Securities Corp. in Vancouver, notes that instead of being   Read More

Based in Oakville, Ont., Canadian healthcare stock Concordia Healthcare Corp. buys and manages legacy pharma products. It also buys and develops orphan drugs. Thanks to a recent acquisition, this healthcare   Read More

John Stephenson, portfolio manager and president of Toronto-based Stephenson & Company Capital Management Inc., says the recent dramatic decline in the greenback is unlikely to be sustained for an extended   Read More

Former Investor’s Digest of Canada editor Carlyle Dunbar argues that deflation is on its way. But when? In the meantime large-cap healthcare and information technology stocks are now starring on   Read More

The new investment includes construction projects for dozens of new and existing stores. This giant in the consumer goods industry is Canada’s largest retailer providing grocery, pharmacy, health and beauty,   Read More

While the United States is entering an extended period of monetary tightening, Europe is beginning its experiment of unbridled and unrestrained monetary stimulus. One thing that investors know from the   Read More

Johnson & Johnson has gone through a spate of recent problems, but its size, earnings record, dividend record, productivity and R & D still make this healthcare solutions giant a   Read More

In mid-2015 Baxter will split into two companies. One will focus on medical products for healthcare solutions; the other on developing and marketing biopharmaceuticals.
On March 9, there was an anniversary   Read More